I'm doing okay right now: on Wednesday I started receiving a bispecific antibody called petosemtamab (https://jakeseliger.com/2023/09/29/clinical-update-about-w

I'm doing okay right now: on Wednesday I started receiving a bispecific antibody called petosemtamab (https://jakeseliger.com/2023/09/29/clinical-update-about-where-the-cancer-is-and-whats-happening-with-treatment/ https://jakeseliger.com/2023/09/29/clinical-update-about-whe... for details), and it's likely the best shot I have at more time.